Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AVArx vs LillyDirect Foundayo

AVArx
Graded #426

Lower grade

vs+11.300000000000004
LillyDirect Foundayo
Graded #165

Higher grade

The verdict

LillyDirect Foundayo takes it — 67.2/100 to 55.9/100.

LillyDirect Foundayo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLillyDirect Foundayo +27
45
72
Dose & formulationLillyDirect Foundayo +19
40
59
Clinical oversightLillyDirect Foundayo +1
77
78
Labs & monitoringEven
52
52
FulfillmentAVArx +5
85
80
Contract termsLillyDirect Foundayo +14
41
55
AVArx · left barLillyDirect Foundayo · right bar

The numbers

MetricAVArxLillyDirect Foundayo
WeighScore55.9/10067.2/100
GradeCC
Scorecard rank#426#165
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
AVArx

Graded #426 · C

Strengths

  • Publishes exactly which states require a live audio or video visit before a prescription, which almost no competitor discloses
  • Names its prescribing group, Arora Health & Aesthetics, and gives a medical compliance contact
  • Terms state service is available to residents of all 50 states, and the shipping policy matches
  • Dates its own editorial reviews on treatment pages
  • HSA/FSA accepted with receipts provided for reimbursement

Where it loses points

  • No price is published anywhere on the site, on treatment pages or in the intake, so you cannot compare before starting a visit
  • Never states whether its semaglutide and tirzepatide are compounded or brand-name
  • No dispensing pharmacy is named, only licensed pharmacies in our network
  • Cancellation terms are not published, only presented at checkout
  • Prescriptions cannot be returned once dispensed, and the refund policy is otherwise unstated
LillyDirect Foundayo

Graded #165 · C

Strengths

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Where it loses points

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard